Edgewise Therapeutics, Inc. (EWTX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US28036F1057
Edgewise Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -191.41 m USD |
| EBIT | -167.79 m USD |
| Net income | -167.80 m USD |
| Diluted EPS – continuing operations | -1.63 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, sevasemten, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials; and EDG-15400, a novel small molecule for the treatment of heart failure with preserved ejection fraction. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.
More stocks
- Takashimaya Co Ltd (8233.T)
- Inner Mongolia Dazhong Mining Co Ltd (001203.SZ)
- Fluidra SA (FDR.MC)
- Shandong Xinchao Energy Co Ltd (600777.SS)
- AZZ INC (AZZ)
- Quectel Wireless Solutions Co Ltd (603236.SS)
- Dmg Mori (GIL.DE)
- Global Power Synergy PCL (GPSC.BK)
- Jinneng Holding Shanxi Coal Industry Co Ltd (601001.SS)
- COMSTOCK RESOURCES INC (CRK)
- Persol Holdings Co Ltd (2181.T)
- Athabasca Oil Corp (ATH.TO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.